Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Drug Deliv Transl Res. 2018 Aug;8(4):964–984. doi: 10.1007/s13346-017-0419-y

Table 2B.

Design of experiment to assess effects of DOX NPs on elastic matrix neoassembly and proteolytic activity in cytokine (TNF-α and IL-1β; 10 ng/ml each)-injured EaRASMC cultures. Outcomes were measured in harvested cell layers at 21 days post-seeding.

Case Cell Amount/ Type/# Cultures Day 7 Serum Starve: 3 h Treatment: 30 min Treatment Day 8 and Day 14
(Till Harvest on Day 21)
1% FBS 10% FBS
Healthy Cell Controls 30K, RASMC, n=3
Treatment Controls 30K, EaRASMC, n=3 Cytokines Cytokines
Blank NPs 30K, EaRASMC, n=3 Blank NPs, Cytokines Blank NPs, Cytokines
DOX NPs 30K, EaRASMC, n=3 DOX NPs, Cytokines DOX NPs, Cytokines